CN Patent

CN118359585A — 共晶体、其药物组合物以及涉及其的治疗方法

Assigned to Les Laboratoires Servier SAS · Expires 2024-07-19 · 2y expired

What this patent protects

本发明提供了可用于治疗癌症的化合物的固体形式、其药物组合物以及治疗癌症的方法，所述方法包括向有需要的患者施用本文所述的固体形式。

USPTO Abstract

本发明提供了可用于治疗癌症的化合物的固体形式、其药物组合物以及治疗癌症的方法，所述方法包括向有需要的患者施用本文所述的固体形式。

Drugs covered by this patent

Patent Metadata

Patent number
CN118359585A
Jurisdiction
CN
Classification
—
Expires
2024-07-19
Drug substance claim
No
Drug product claim
No
Assignee
Les Laboratoires Servier SAS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.